Off-label drug prescribing in a Portuguese Paediatric Emergency Unit

International Journal of Clinical Pharmacy

Volumn 35, Issue 1, 2013, Pages 30-36

  Ribeiro, Marina ^a   Jorge, Arminda ^a,b   MacEdo, Ana Filipa ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b Hospital Center Cova da Beira   (Portugal)

Author keywords

Children; Off label prescribing; Paediatrics; Portugal; Prescription

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AUGMENTIN ES; BEN U RON; IBUPROFEN; PARACETAMOL; SALBUTAMOL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILD HEALTH CARE; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG MISUSE; EMERGENCY WARD; FEMALE; HOSPITAL DISCHARGE; HUMAN; INAPPROPRIATE PRESCRIBING; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OFF LABEL DRUG USE; PEDIATRIC WARD; PORTUGAL; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD; TONSILLITIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; OFF-LABEL USE; PEDIATRICS; PORTUGAL;

EID: 84874656450     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-012-9699-y     Document Type: Article

References (34)

1. Di Paolo ER, Stoetter H, Cotting J, Frey P, Gehri M, Beck-Popovic M, et al. Unlicensed and off-label drug use in a Swiss paediatric university hospital. Swiss Med Wkly. 2006;136(13-14):218-22.
2. Muhlbauer B, Janhsen K, Pichler J, Schoettler P. Off-label use of prescription drugs in childhood and adolescence: an analysis of prescription patterns in Germany. Dtsch Arztebl Int. 2009;106(3):25-31.
3. Yaffe SJ, Aranda JV. Neonatal and pediatric pharmacology: therapeutic principles in practice. 4th ed. Philadelphia: WB Saunders; 2010. ISBN: 9780781795388.
4. Duarte D. Medicamentos para Crianças A realidade actual na União Europeia. Revista Lusófona de Ciências e Tecnologia da Saúde. 2006;3(1):9-18.
5. Venitz J, Sittner We. Appropriate dose selection - how to optimize clinical drug development. Vol. 59. Springer; 2007. p. 111-134.
6. Meadows M. Drug research and children. FDA Consum. 2003;37(1):12-7.
7. Winterfeld U, Le Heuzey MF, Acquaviva E, Mouren MC, Brion F, Bourdon O. Utilisation hors autorisation de mise sur le marché (AMM) des psychotropes en pédiatrie: une étude prospective. Arch Pediatr. 2009;16(9):1252-60.
8. Strolin Benedetti M, Baltes EL. Drug metabolism and disposition in children. Fundam Clin Pharmacol. 2003;17(3):281-99.
9. Kimland E, Bergman U, Lindemalm S, Bottiger Y. Drug related problems and off-label drug treatment in children as seen at a drug information centre. Eur J Pediatr. 2007;166(6):527-32.
10. Novak E, Allen PJ. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics. Pediatr Nurs. 2007;33(1):64-70.
11. Johnson TN. The problems in scaling adult drug doses to children. Arch Dis Child. 2008;93(3):207-11.
12. ICH Guidance E11: "Note for Guidance on Clinical Investigation of Medicinal Products in the Paediatric Population" (CPMP/ICH/2711/99) [on-line]. Available from: http://www.ema.europa.eu/pdfs/human/ich/271199en.pdf. Accessed July 2012.
13. Amending Regulation EC No 1902/2006 on Medicinal Products for Paediatric Use [on-line]. Available from: http://ec.europa.eu/health/files/eudralex/vol-1/ reg-2006-1902/reg-2006-1902-en.pdf. Accessed July 2012.
14. Autret-Leca E, Bensouda-Grimaldi L, Le Guellec C, Jonville-Béra AP. L'enfant et les médicaments: application à la prescription en pédiatrie. Archives de Pédiatrie. 2005;13:181-5.
15. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005;164(9):552-8.
16. Gazarian M, Kelly M, McPhee JR, Graudins LV, Ward RL, Campbell TJ. Off-label use of medicines: consensus recommendations for evaluating appropriateness. Med J Aust. 2006;185(10):544-8.
17. McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child. 2000;83(6):498-501.
18. Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 1999;88(9):965-8.
19. Jonville-Bera AP, Bera F, Autret-Leca E. Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study. Eur J Clin Pharmacol. 2005;61(3):231-6.
20. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ. 2000;320(7227):79-82.
21. Shah SS, Hall M, Goodman DM, Feuer P, Sharma V, Fargason C Jr, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161(3):282-90.
22. Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther. 2009;34(3):277-87.
23. Morales-Carpi C, Estan L, Rubio E, Lurbe E, Morales-Oliva FJ. Drug utilization and off-label drug use among Spanish emergency room paediatric patients. Eur J Clin Pharmacol. 2010;66:315-20.
24. Instituto Nacional de Estatística [on-line]. Available from: http://www.ine.pt. Accessed July 2012.
25. International Statistical Classification of Diseases and Related Health Problems - ICD-10 [on-line]. Available from: http://apps.who.int/ classifications/apps/icd/icd10online/. Accessed July 2012.
26. Anatomical Therapeutic Chemical Code - ATC [on-line]. Available from: http://www.whocc.no/atc-ddd-index/. Accessed July 2012.
27. Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol. 2002;54(6):665-70.
28. Jain SS, Bavdekar SB, Gogtay NJ, Sadawarte PA. Off-label drug use in children. Indian J Pediatr. 2008;75(11):1133-6.
29. Bajcetic M, Jelisavcic M, Mitrovic J, Divac N, Simeunovic S, Samardzic R, et al. Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol. 2005;61(10):775-9.
30. 't Jong GW, Eland IA, Sturkenboom MC, van den Arker JN, Strickerf BH. Unlicensed and off-label prescription of respiratory drugs to children. Eur Respir J. 2004;23(2):310-3.
31. Hsien L, Breddemann A, Frobel AK, Heusch A, Schmidt KG, Laer S. Off-label drug use among hospitalised children: identifying areas with the highest need for research. Pharm World Sci. 2008;30(5):497-502.
32. Report on the survey of all paediatric uses of medicinal products in Europe [on-line]. Available from: http://www.ema.europa.eu/docs/en-GB/document- library/Report/2011/01/WC500101006.pdf. Accessed July 2012.
33. 't Jong G, Eland IA, Strickerf BH, van den Anker JN. Information for paediatric use of medicines in a product information compendium. Paediatr Perinatal Drug Ther. 2001;4(4):148-51.
34. Smith AR, Barbato A, Beydon N, Bisgaard H, de Boeck K, Brand P, et al. Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J. 2010;35:247-65.